ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

RLMD Relmada Therapeutics Inc

3,725
0,035 (0,95%)
Dernière mise à jour : 19:12:43
Retardé de 15 minutes

Période:

Mode Dessin:

Volume 4 357
Prix Achat 3,71
Prix Vente 3,74
Actualités -
Maximum Haut 3,78

Bas
2,3601

Sur 52 semaines

Haut
7,2225

Minimum Bas 3,725
Nom Action Symbole Action Marché Type
Relmada Therapeutics Inc RLMD NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
0,035 0,95% 3,725 19:12:43
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
3,73 3,725 3,78 3,69
Transactions Totales Volume échangé VWAP Volume Financier Volume en moyenne Sur 52 semaines
131 4 357 US$ 3,76 US$ 16 380 - 2,3601 - 7,2225
Dernière Transaction Type Quantités échangées Prix transaction Devise
19:15:12 100 US$ 3,725 USD

Bilan Comptable

Capitalisation Boursière Actions en Circulation Float Chiffre d'affaires Bénéfice/Perte BPA Ratio Cours sur Bénéfices
112,57M 30,10M - 0 -98,79M -3,28 -
Short Interest Dividendes Par Action Rendement du Dividende Ex-Div Date Insider B/S Insider % Owned
- - - -

plus d’informations financières »

Actualités Action Relmada Therapeutics

Date Heure Source Titre
19/3/202412:27IH Market NewsUS Index Futures Decline Ahead of Federal Reserve Meeting,..
20/2/202423:55Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
14/2/202414:53Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial..
01/2/202400:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
01/2/202400:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
01/2/202400:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
11/1/202422:30Edgar (US Regulatory)Form 8-K - Current report
04/1/202414:11Edgar (US Regulatory)Form 8-K - Current report
03/1/202423:00Edgar (US Regulatory)Form 8-K - Current report
19/12/202323:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
19/12/202323:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
19/12/202323:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..

Forum Action Relmada Therapeutics

Aucune Discussion TrouvéeAjouter une Discussion

Historiques Relmada Therapeutics Inc

Période Ouver. Haut Bas VWAP Moyenne Vol. Quot. Variation %
1 semaine3,733,96943,353,63123 061-0,005-0,13%
1 mois4,755,093,354,18119 150-1,03-21,58%
3 mois5,177,22253,355,15182 537-1,45-27,95%
6 mois3,007,22252,4154,06236 9270,72524,17%
1 an2,707,22252,36013,57203 9201,0337,96%
3 ans38,9439,661,8112,08326 240-35,22-90,43%
5 ans10,8554,001,8116,69258 159-7,13-65,67%

Dernières Valeurs Consultées

Delayed Upgrade Clock